Treatment of Moderate to Severe Plaque Psoriasis

PHASE2RecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

August 27, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

September 30, 2026

Conditions
Plaque Psoriasis
Interventions
DRUG

TQH3906 capsules

To assess the efficacy and safety of TQH3906 in subjects with moderate to severe plaque psoriasis.

DRUG

Placebo of TQH3906 capsules

Placebo without drug substance.

Trial Locations (35)

20025

NOT_YET_RECRUITING

Shanghai JiaoTong University of medicine Ruijin Hospital, Shanghai

50000

NOT_YET_RECRUITING

Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang

NOT_YET_RECRUITING

The Second Hospital of HeBei Medical University, Shijiazhuang

100730

NOT_YET_RECRUITING

Beijing Tongren Hospital, Capital Medical University, Beijing

110000

NOT_YET_RECRUITING

Shengjing Hospital of China Medical University, Shenyang

110001

NOT_YET_RECRUITING

The first hospital of china medical university, Shenyang

124000

NOT_YET_RECRUITING

Genertec Liaoyou Gem Flower Hospital, Panjin

130031

NOT_YET_RECRUITING

The First Bethune Hospital of Jilin University, Changchun

135000

NOT_YET_RECRUITING

Meihekou Central Hospital, Meihekou

150036

NOT_YET_RECRUITING

Heilongjiang Provincial Hospital, Harbin

210000

RECRUITING

Hospital of Dermatology, Chinese Academy of Medical Sciences, Nanjing

215006

NOT_YET_RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

224006

NOT_YET_RECRUITING

Yancheng First People's Hospital, Yancheng

241000

NOT_YET_RECRUITING

The Second Affiliated Hospital of Wannan Medical College, Wuhu

250022

NOT_YET_RECRUITING

Shandong First Medical University Affiliated Dermatology Hospital, Jinan

250063

NOT_YET_RECRUITING

Shandong University Qilu Hospital, Jinan

266011

NOT_YET_RECRUITING

Qingdao Municipal hospital (group), Qingdao

266033

RECRUITING

Qingdao Traditional Chinese Medicine Hospital, Qingdao

300120

NOT_YET_RECRUITING

Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin

310003

NOT_YET_RECRUITING

Affiliated Hangzhou First People'S Hospital,School of Medicine, Westlake University, Hangzhou

310009

NOT_YET_RECRUITING

The Second Affiliated Hospital Zhejiang University School Of Medicine, Hangzhou

400042

NOT_YET_RECRUITING

The first affiliated hospital of chongqing medical university, Chongqing

410000

NOT_YET_RECRUITING

The Third Xiangya Hospital of Central South University, Changsha

415100

NOT_YET_RECRUITING

The First People's Hospital of Changde, Changde

430033

NOT_YET_RECRUITING

Wuhan First Hospital, Wuhan

442000

NOT_YET_RECRUITING

Shiyan Renmin Hospital, Shiyan

471000

NOT_YET_RECRUITING

The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang

473010

NOT_YET_RECRUITING

Nanyang First People'S Hospital, Nanyang

510091

NOT_YET_RECRUITING

Dermatology Hospital of Southern Medical University, Guangzhou

545006

NOT_YET_RECRUITING

Liuzhou People'S Hospital, Liuzhou

710000

NOT_YET_RECRUITING

The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an

830001

NOT_YET_RECRUITING

Xinjiang Uygur Autonomous Region People's Hospital, Ürümqi

054002

NOT_YET_RECRUITING

The Second Affiliated Hospital Of Xingtai Medical Colledge, Xingtai

014000

NOT_YET_RECRUITING

The First Affiliated Hospital of Baotou Medical College, Baotou

030012

NOT_YET_RECRUITING

Shanxi Provincial People's Hospital, Taiyuan

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

INDUSTRY